Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin

Int J Antimicrob Agents. 2013 Feb;41(2):197-9. doi: 10.1016/j.ijantimicag.2012.09.016. Epub 2012 Nov 10.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects*
  • Cohort Studies
  • Colistin / administration & dosage*
  • Colistin / adverse effects*
  • Drug Resistance, Multiple, Bacterial*
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Female
  • France
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Osteoarthritis / drug therapy*
  • Osteoarthritis / microbiology
  • Retrospective Studies
  • Switzerland
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Colistin